SCNDOTCLaboratory Analytical InstrumentsUS GAAP · USD

Scientific Industries Inc

Scientific Industries Inc. designs, manufactures, and markets benchtop laboratory equipment and bioprocessing systems through its operating subsidiaries in the United States and Germany. Its products are used in laboratory-scale research and bioprocessing workflows across academic, pharmaceutical, healthcare, and industrial research settings.

Revenue5.1m USD
+5.4 %y/y
Operating profit (EBIT)-7.9m USD
+4.0 %y/y
EBIT margin-156.1%
+15.2 ppy/y
Net income-1.2m USD
+81.1 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

-15-10-5051015m USD2020: 8.6 m USD2020: EBIT -1.1 m USD20202021: 9.8 m USD2021: EBIT -4.7 m USD20212022: 11 m USD2022: EBIT -12 m USD20222023: 11 m USD2023: EBIT -9.3 m USD20232024: 4.8 m USD2024: EBIT -8.2 m USD20242025: 5.1 m USD2025: EBIT -7.9 m USD20255.1-7.9
RevenueOperating profit (EBIT)

Business

Share of revenue
Benchtop Laboratory Equipment60 %

Standard laboratory instruments sold for research and routine lab workflows, including Genie and Torbal products.

Bioprocessing Systems35 %

Systems and products used in bioprocessing and laboratory-scale process development.

OEM and Specialty Laboratory Products5 %

Custom or OEM-oriented Torbal products and related laboratory equipment offerings.

Customers

The company sells primarily to research-oriented institutions and organizations that need compact laboratory equipment or bioprocessing tools for experimentation and development. Its customer base includes universities, pharmaceutical companies, pharmacies, national laboratories, medical device manufacturers, and other industrial research users.

Universities and academic research labs

Buy benchtop instruments and bioprocessing tools for teaching, experimentation, and research programs.

Pharmaceutical companies

Purchase laboratory equipment and bioprocessing systems for drug research and development workflows.

National laboratories

Use specialized benchtop equipment for controlled research and testing applications.

Medical device manufacturers

Buy lab-scale instruments for product development, validation, and testing.

Pharmacies and other industrial research users

Purchase compact laboratory equipment for applied research and formulation work.

Strategy

The company’s strategy centers on maintaining a portfolio of benchtop laboratory equipment while developing bioprocessing systems and new products through its Scientific Bioprocessing platform. It also appears to rely on product development, OEM relationships, and international operating capabilities to broaden its research-market reach.

Expand bioprocessing product developmentMedium term

New products can broaden the addressable market beyond legacy benchtop equipment.

Support the core benchtop equipment franchiseShort term

Established laboratory products provide the base customer relationships and operating cash generation.

Leverage international operating structureMedium term

The German subsidiary can support product development, sourcing, and sales into European research markets.

Geography

Scientific Industries is headquartered in the United States and operates through U.S. and German subsidiaries, giving it a transatlantic manufacturing and commercial footprint. The available filings identify the U.S. and Germany as core operating locations, with products sold into research markets that can be sensitive to funding cycles, trade conditions, and cross-border supply costs.

Risks

Demand depends on research budgets, customer funding, and the timing of lab purchasing decisions, which can make revenue uneven. The company also faces tariff exposure, trade-war uncertainty, and product-development risk because it sells specialized instruments with some components and OEM inputs subject to cost pressure and launch timing uncertainty.

Sorted by severity
Reduced research fundingHigh

Customers in academia and research-heavy industries may delay or reduce equipment purchases when budgets tighten.

ExposureUniversitiesLabsResearch customers
Global trade war and tariff exposureHigh

Imported components and OEM products can become more expensive, pressuring gross margin and pricing.

Exposure: Torbal OEM products and supply chain inputs

Product development and launch timingMedium

Bioprocessing revenue depends on customer acceptance and availability of new products.

Exposure: DOTS and bioprocessing systems

Customer order delaysMedium

Specialized instruments are often purchased after funding approvals or technical finalization, creating timing volatility.

Exposure: Bioprocessing Systems Operations

Accounting

Judgemental items
Revenue recognition timing

Specialized equipment sales may depend on shipment, installation, or customer acceptance timing.

Impact: Can shift quarterly revenue and comparability

Inventory valuation and overhead absorption

Lower production volumes can leave fixed overhead under-absorbed and affect margins.

Impact: Affects gross profit and inventory carrying values

Foreign currency translation

The German subsidiary creates exposure to euro-denominated operations and translation effects.

Impact: Can affect reported earnings and equity

Going-concern and liquidity judgments

Management must assess whether available cash and financing are sufficient to fund operations.

Impact: Can influence financial statement presentation and disclosure

Publicly listed companies with a comparable business focus.

Last updated: 29/04/2026

Scientific Industries Inc (OTC) – Laboratory Analytical Instruments | Financial Analysis – Clarifo